Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and<i>Npc1l1</i><sup>−/−</sup>mice
Eric D. Labonté(University of Cincinnati), Philip N. Howles(University of Cincinnati Medical Center), Juan Camilo Rojas Echeverri, Patrick Tso(University of Cincinnati), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), Joanna P. Davies(Icahn School of Medicine at Mount Sinai), Dean Gilham(Resverlogix (Canada)), David Y. Hui(University of Cincinnati Medical Center), Ronald J. Jandacek, Lisa M. Camarota
American Journal of Physiology-Gastrointestinal and Liver Physiology
August 22, 2008
Cited by 114
Related Papers
Transforming growth factor–β3 is required for secondary palate fusion
|Nature Genetics|1995|904
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.
|Journal of Clinical Investigation|1989|535
Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
|Science Translational Medicine|2018|411
Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe
|Journal of Clinical Investigation|2007|372